Ekso GT™ Robotic Exoskeleton Cleared by FDA for Use with Stroke and Spinal Cord Injury Patients

RICHMOND, Calif., Apr. 4 (Korea Bizwire) — Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke, individuals with spinal cord injuries [...]